Molecular signatures of peripheral blood mononuclear cells during chronic interferon-α treatment: Relationship with depression and fatigue

Psychological Medicine

Volumn 42, Issue 8, 2012, Pages 1591-1603

  Felger, J C ^a   Cole, S W ^b,c,d   Pace, T W W ^a   Hu, F ^a   Woolwine, B J ^a   Doho, G H ^e   Raison, C L ^a   Miller, A H ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

2 5 oligoadenylate synthetase; Depression; fatigue; gene array; interferon

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ALPHA INTERFERON; ANTIVIRUS AGENT; MESSENGER RNA; RIBAVIRIN;

ARTICLE; BIOLOGY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CLINICAL TRIAL; DEPRESSION; DRUG COMBINATION; DRUG EFFECT; FATIGUE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEPATITIS C; HUMAN; IMMUNOLOGY; LONGITUDINAL STUDY; MALE; METHODOLOGY; MICROARRAY ANALYSIS; MIDDLE AGED; MONONUCLEAR CELL; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STATISTICS;

2',5'-OLIGOADENYLATE SYNTHETASE; ANTIVIRAL AGENTS; COMPUTATIONAL BIOLOGY; DEPRESSION; DRUG THERAPY, COMBINATION; FATIGUE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX;

EID: 84863965319     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711002868     Document Type: Article

References (73)

1. Akwa Y, Hassett DE, Eloranta ML, Sandberg K, Masliah E, Powell H, Whitton JL, Bloom FE, Campbell IL (1998). Transgenic expression of IFN-alpha in the central nervous system of mice protects against lethal neurotropic viral infection but induces inflammation and neurodegeneration. Journal of Immunology 161, 5016-5026. (Pubitemid 28492084)
2. Blendy JA (2006). The role of CREB in depression and antidepressant treatment. Biological Psychiatry 59, 1144-1150.
3. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003). A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19, 185-193. (Pubitemid 36181903)
4. Bower JE, Ganz PA, Aziz N, Fahey JL (2002). Fatigue and proinflammatory cytokine activity in breast cancer survivors. Psychosomatic Medicine 64, 604-611. (Pubitemid 34791163)
5. Bower JE, Ganz PA, Irwin MR, Arevalo JM, Cole SW (2011). Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue. Brain, Behavior, and Immunity 25, 147-150.
6. Chen G, Hasanat KA, Bebchuk JM, Moore GJ, Glitz D, Manji HK (1999). Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressants. Psychosomatic Medicine 61, 599-617. (Pubitemid 29455084)
7. Cole SW, Galic Z, Zack JA (2003). Controlling false-negative errors in microarray differential expression analysis: a PRIM approach. Bioinformatics 19, 1808-1816. (Pubitemid 37220473)
8. Cole SW, Hawkley LC, Arevalo JM, Cacioppo JT (2011). Transcript origin analysis identifies antigen-presenting cells as primary targets of socially regulated gene expression in leukocytes. Proceedings of the National Academy of Science USA 108, 3080-3085.
9. Cole SW, Yan W, Galic Z, Arevalo J, Zack JA (2005). Expression-based monitoring of transcription factor activity: the TELiS database. Bioinformatics 21, 803-810. (Pubitemid 40439417)
10. Darnell Jr. JE, Kerr IM, Stark GR (1994). Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421. (Pubitemid 24217131)
11. Evans DL, Charney DS, Lewis L, Golden RN, Gorman JM, Krishnan KR, Nemeroff CB, Bremner JD, Carney RM, Coyne JC, Delong MR, Frasure-Smith N, Glassman AH, Gold PW, Grant I, Gwyther L, Ironson G, Johnson RL, Kanner AM, Katon WJ, Kaufmann PG, Keefe FJ, Ketter T, Laughren TP, Leserman J, Lyketsos CG, McDonald WM, McEwen BS, Miller AH, Musselman D, O'Connor C, Petitto JM, Pollock BG, Robinson RG, Roose SP, Rowland J, Sheline Y, Sheps DS, Simon G, Spiegel D, Stunkard A, Sunderland T, Tibbits Jr. P, Valvo WJ (2005). Mood disorders in the medically ill: scientific review and recommendations. Biological Psychiatry 58, 175-189. (Pubitemid 41112265)
12. Evans DL, Folds JD, Petitto JM, Golden RN, Pedersen CA, Corrigan M, Gilmore JH, Silva SG, Quade D, Ozer H (1992). Circulating natural killer cell phenotypes in men and women with major depression. Relation to cytotoxic activity and severity of depression. Archives of General Psychiatry 49, 388-395.
13. Felger JC, Alagbe O, Pace TW, Woolwine BJ, Hu F, Raison CL, Miller AH (2011). Early activation of p38 mitogen activated protein kinase is associated with interferon-alpha-induced depression and fatigue. Brain, Behavior, and Immunity 25, 1094-1098.
14. First MB, Spitzer RL, Gibbon M, Williams JB (1997). Structured Clinical Interview for DSM-IV. American Psychiatric Press: Washington, DC.
15. Folstein MF, Folstein SE, McHugh PR (1975). ' Mini-mental state '. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 12, 189-198.
16. Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X (2006). Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. Proceedings of the National Academy of Science USA 103, 2770-2775.
17. Haque SJ, Williams BR (1998). Signal transduction in the interferon system. Seminars in Oncology 25, 14-22. (Pubitemid 28093151)
18. Irwin M, Patterson T, Smith TL, Caldwell C, Brown SA, Gillin JC, Grant I (1990). Reduction of immune function in life stress and depression. Biological Psychiatry 27, 22-30. (Pubitemid 20035217)
19. Kearns NP, Cruickshank CA, McGuigan KJ, Riley SA, Shaw SP, Snaith RP (1982). A comparison of depression rating scales. British Journal of Psychiatry 141, 45-49. (Pubitemid 12074468)
20. Klimas NG, Koneru AO (2007). Chronic fatigue syndrome: inflammation, immune function, and neuroendocrine interactions. Current Rheumatology Reports 9, 482-487. (Pubitemid 350305206)
21. Klimas NG, Salvato FR, Morgan R, Fletcher MA (1990). Immunologic abnormalities in chronic fatigue syndrome. Journal of Clinical Microbiology 28, 1403-1410. (Pubitemid 20194439)
22. Koch JM, Kell S, Hinze-Selch D, Aldenhoff JB (2002). Changes in CREB-phosphorylation during recovery from major depression. Journal of Psychiatric Research 36, 369-375. (Pubitemid 35256155)
23. Kojima M, Kojima T, Suzuki S, Oguchi T, Oba M, Tsuchiya H, Sugiura F, Kanayama Y, Furukawa TA, Tokudome S, Ishiguro N (2009). Depression, inflammation, and pain in patients with rheumatoid arthritis. Arthritis and Rheumatism 61, 1018-1024.
24. Kozora E, Ellison MC, West S (2006). Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Arthritis and Rheumatism 55, 628-635. (Pubitemid 44289884)
25. Krishnaraju K, Nguyen HQ, Liebermann DA, Hoffman B (1995). The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Molecular and Cellular Biology 15, 5499-5507.
26. Kuipers SD, Trentani A, Westenbroek C, Bramham CR, Korf J, Kema IP, Ter Horst GJ, Den Boer JA (2006). Unique patterns of FOS, phospho-CREB and BrdU immunoreactivity in the female rat brain following chronic stress and citalopram treatment. Neuropharmacology 50, 428-440. (Pubitemid 43209039)
27. Kyriakis JM, Avruch J (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiological Reviews 81, 807-869. (Pubitemid 32267078)
28. Lai IC, Hong CJ, Tsai SJ (2003). Expression of cAMP response element-binding protein in major depression before and after antidepressant treatment. Neuropsychobiology 48, 182-185.
29. Lotrich FE (2009). Major depression during interferon-alpha treatment: vulnerability and prevention. Dialogues in Clinical Neurosciences 11, 417-425.
30. Lutgendorf SK, DeGeest K, Sung CY, Arevalo JM, Penedo F, Lucci 3rd J, Goodheart M, Lubaroff D, Farley DM, Sood A, Cole SW (2009). Depression, social support, and beta-adrenergic transcription control in human ovarian cancer. Brain, Behavior, and Immunity 23, 176-183.
31. Maddock C, Baita A, Orru MG, Sitzia R, Costa A, Muntoni E, Farci MG, Carpiniello B, Pariante CM (2004). Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms. Journal of Psychopharmacology 18, 41-46. (Pubitemid 38623092)
32. Majer M, Welberg LA, Capuron L, Pagnoni G, Raison CL, Miller AH (2008). IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain, Behavior, and Immunity 22, 870-880.
33. Manji HK, Bebchuk JM, Moore GJ, Glitz D, Hasanat KA, Chen G (1999). Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implications. Journal of Clinical Psychiatry 60 (Suppl. 2), 27-39; discussion 40-21, 113-116.
34. Merritt JA, Borden EC, Ball LA (1985). Measurement of 2k,5k-oligoadenylate synthetase in patients receiving interferon-alpha. Journal of Interferon Research 5, 191-198. (Pubitemid 15086883)
35. Miller AH (2009). Norman Cousins Lecture. Mechanisms of cytokine-induced behavioral changes: psychoneuroimmunology at the translational interface. Brain, Behavior, and Immunity 23, 149-158.
36. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, Doll R, Ma R, Cole SW (2008). A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biological Psychiatry 64, 266-272.
37. Moeenrezakhanlou A, Shephard L, Lam L, Reiner NE (2008). Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. Journal of Leukocyte Biology 84, 519-528.
38. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Brtish Journal of Psychiatry 134, 382-389. (Pubitemid 9136500)
39. Morinobu S, Nibuya M, Duman RS (1995). Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology 12, 221-228.
40. Musselman DL, Lawson DH, Gumnick JF, Manatunga AK, Penna S, Goodkin RS, Greiner K, Nemeroff CB, Miller AH (2001). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine 344, 961-966. (Pubitemid 32240314)
41. Ng WF, Bowman SJ (2010). Primary Sjögren's syndrome: too dry and too tired. Rheumatology (Oxford) 49, 844-853.
42. Nijs J, De Meirleir K (2005). Impairments of the 2-5A synthetase/RNase L pathway in chronic fatigue syndrome. In Vivo 19, 1013-1021.
43. Okuno T, Shindo M, Arai K, Matsumoto M, Takeda M, Kashima K, Sokawa Y (1991). 2k,5k-Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis. Gastroenterologica Japonica 26, 603-610.
44. Pariante CM, Miller AH (1995). Natural killer cell activity in major depression: a prospective study of the in vivo effects of desmethylimipramine treatment. European Neuropsychopharmacology 5 (Suppl.), 83-88. (Pubitemid 26017264)
45. Pfeffer LM, Dinarello CA, Herberman RB, Williams BR, Borden EC, Bordens R, Walter MR, Nagabhushan TL, Trotta PP, Pestka S (1998). Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Research 58, 2489-2499. (Pubitemid 28275413)
46. Potter GG, Kittinger JD, Wagner HR, Steffens DC, Krishnan KR (2004). Prefrontal neuropsychological predictors of treatment remission in late-life depression. Neuropsychopharmacology 29, 2266-2271. (Pubitemid 39578919)
47. Raison CL, Borisov AS, Majer M, Drake DF, Pagnoni G, Woolwine BJ, Vogt GJ, Massung B, Miller AH (2009a). Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression. Biological Psychiatry 65, 296-303.
48. Raison CL, Borisov AS, Woolwine BJ, Massung B, Vogt G, Miller AH (2010a). Interferon-alpha effects on diurnal hypothalamic-pituitary-adrenal axis activity: relationship with proinflammatory cytokines and behavior. Molecular Psychiatry 15, 535-547.
49. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31. (Pubitemid 43083561)
50. Raison CL, Dantzer R, Kelley KW, Lawson MA, Woolwine BJ, Vogt G, Spivey JR, Saito K, Miller AH (2010b). CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression. Molecular Psychiatry 15, 393-403.
51. Raison CL, Demetrashvili M, Capuron L, Miller AH (2005). Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19, 105-123. (Pubitemid 40321763)
52. Raison CL, Lin JM, Reeves WC (2009b). Association of peripheral inflammatory markers with chronic fatigue in a population-based sample. Brain, Behavior, and Immunity 23, 327-337.
53. Reeves WC, Wagner D, Nisenbaum R, Jones JF, Gurbaxani B, Solomon L, Papanicolaou DA, Unger ER, Vernon SD, Heim C (2005). Chronic fatigue syndrome-a clinically empirical approach to its definition and study. BMC Medicine 3, 19.
54. Ronnblom L, Eloranta ML, Alm GV (2003). Role of natural interferon-alpha producing cells (plasmacytoid dendritic cells) in autoimmunity. Autoimmunity 36, 463-472. (Pubitemid 37498242)
55. Saha S, Rangarajan PN (2003). Common host genes are activated in mouse brain by Japanese encephalitis and rabies viruses. Journal of General Virology 84, 1729-1735. (Pubitemid 36805907)
56. Sandberg K, Eloranta ML, Campbell IL (1994). Expression of alpha/beta interferons (IFN-alpha/beta) and their relationship to IFN-alpha/beta-induced genes in lymphocytic choriomeningitis. Journal of Virology 68, 7358-7366. (Pubitemid 24328791)
57. Sanders VM, Straub RH (2002). Norepinephrine, the beta-adrenergic receptor, and immunity. Brain, Behavior, and Immunity 16, 290-332.
58. Smets EM, Garssen B, Bonke B, De Haes JC (1995). The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. Journal of Psychosomatic Research 39, 315-325.
59. Suhadolnik RJ, Reichenbach NL, Hitzges P, Adelson ME, Peterson DL, Cheney P, Salvato P, Thompson C, Loveless M, Muller WE, Schröder HC, Strayer DR, CarterWA (1994a). Changes in the 2-5A synthetase/RNase L antiviral pathway in a controlled clinical trial with poly(I)-poly(C12U) in chronic fatigue syndrome. In Vivo 8, 599-604. (Pubitemid 24341140)
60. Suhadolnik RJ, Reichenbach NL, Hitzges P, Sobol RW, Peterson DL, Henry B, Ablashi DV, Muller WE, Schroder HC, Carter WA, Strayer DR (1994b). Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clinical Infectious Diseases 18 (Suppl. 1), S96-S104. (Pubitemid 24023893)
61. Taylor JL, Grossberg SE (1998). The effects of interferon-alpha on the production and action of other cytokines. Seminars in Oncology 25, 23-29. (Pubitemid 28093152)
62. Taylor MW, Grosse WM, Schaley JE, Sanda C, Wu X, Chien SC, Smith F, Wu TG, Stephens M, Ferris MW, McClintick JN, Jerome RE, Edenberg HJ (2004). Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro. Journal of Interferon and Cytokine Research 24, 107-118. (Pubitemid 38253638)
63. Trask PC, Esper P, Riba M, Redman B (2000). Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions. Journal of Clinical Oncology 18, 2316-2326. (Pubitemid 30350225)
64. Tusher VG, Tibshirani R, Chu G (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Science USA 98, 5116-5121. (Pubitemid 32397092)
65. Vojdani A, Ghoneum M, Choppa PC, Magtoto L, Lapp CW (1997). Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA. Journal of Internal Medicine 242, 465-478. (Pubitemid 28015718)
66. Vojdani A, Lapp CW (1999). Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome. Immunopharmacology and Immunotoxicology 21, 175-202. (Pubitemid 29207208)
67. Wallace TL, Stellitano KE, Neve RL, Duman RS (2004). Effects of cyclic adenosine monophosphate response element binding protein overexpression in the basolateral amygdala on behavioral models of depression and anxiety. Biological Psychiatry 56, 151-160. (Pubitemid 38969147)
68. Wang J, Campbell IL, Zhang H (2008). Systemic interferonalpha regulates interferon-stimulated genes in the central nervous system. Molecular Psychiatry 13, 293-301. (Pubitemid 351272648)
69. Wang J, Dunn AJ, Roberts AJ, Zhang H (2009). Decreased immobility in swimming test by homologous interferon-alpha in mice accompanied with increased cerebral tryptophan level and serotonin turnover. Neuroscience Letters 452, 96-100.
70. Wichers MC, Koek GH, Robaeys G, Praamstra AJ, Maes M (2005). Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychological Medicine 35, 433-441. (Pubitemid 40372481)
71. Yamada S, Yamamoto M, Ozawa H, Riederer P, Saito T (2003). Reduced phosphorylation of cyclic AMP-responsive element binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. Journal of Neural Transmission 110, 671-680. (Pubitemid 36683520)
72. Yirmiya R, Pollak Y, Morag M, Reichenberg A, Barak O, Avitsur R, Shavit Y, Ovadia H, Weidenfeld J, Morag A, Newman ME, Pollmächer T (2000). Illness, cytokines, and depression. Annals of the New York Academy of Sciences 917, 478-487.
73. Zarubin T, Han J (2005). Activation and signaling of the p38 MAP kinase pathway. Cell Research 15, 11-18. (Pubitemid 41653958)